Want to see GB:KOO full AI Analyst Report?
Top Page
Kooth
(LSE:KOO)
Select Model
Select Model
Rating:79Outperform
Price Target:
177.00 p
▲(53.91% Upside)
Action:Upgraded
Date:05/22/26
The score is driven mainly by strong financial quality (especially a zero-debt balance sheet and improved profitability) and very attractive P/E-based valuation. These positives are tempered by 2025 revenue and cash-flow softness versus 2024 and an overbought technical setup despite a strong uptrend.
Positive Factors
Zero / minimal debt and stronger equity base
Near-zero debt and a materially larger equity base improve solvency and financial optionality long-term. This durable strength lowers refinancing risk, enables competitive bidding for public contracts, and provides capacity to invest in product, ops, or M&A without levering the business.
Negative Factors
Sharp cash-flow step-down in 2025
A large decline in operating and free cash flow within one year raises concerns about working-capital timing, billing/collection patterns, or contract phasing. Persistent volatility in cash generation reduces the predictability of funding for growth and increases sensitivity to contract timing.
Read all positive and negative factors
Positive Factors
Negative Factors
Zero / minimal debt and stronger equity base
Near-zero debt and a materially larger equity base improve solvency and financial optionality long-term. This durable strength lowers refinancing risk, enables competitive bidding for public contracts, and provides capacity to invest in product, ops, or M&A without levering the business.
Read all positive factors
Kooth (KOO) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£59.67M
Dividend YieldN/A
Average Volume (3M)141.76K
Price to Earnings (P/E)21.0
Beta (1Y)0.90
Revenue Growth-5.18%
EPS Growth-66.95%
CountryUK
Employees554
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.08
Shares Outstanding36,272,137
10 Day Avg. Volume194,228
30 Day Avg. Volume141,758
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)1.32
Price to Sales (P/S)0.66
P/FCF Ratio6.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£360.00Price Target Upside213.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.09
Revenue Forecast (FY)£63.13M
Kooth Business Overview & Revenue Model
Company Description
Kooth plc, together with its subsidiaries, provides digital mental health services to children, young people, and adults in the United Kingdom. It operates online platforms that offers various therapeutic support and interventions, including anony...
How the Company Makes Money
Kooth primarily makes money by contracting with public-sector and public-sector-funded commissioners to provide population-level digital mental health services. Its core revenue stream is business-to-government (and related public commissioning) s...
Kooth Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
88
Very Positive
Cash Flow
64
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 63.29M | 66.74M | 33.34M | 20.12M | 16.68M |
| Gross Profit | 40.09M | 51.99M | 25.86M | 13.86M | 11.59M |
| EBITDA | 10.23M | 14.53M | 1.51M | 1.32M | 1.65M |
| Net Income | 2.61M | 8.03M | -169.00K | -716.00K | -310.00K |
Balance Sheet | |||||
| Total Assets | 39.26M | 43.03M | 30.68M | 16.14M | 13.78M |
| Cash, Cash Equivalents and Short-Term Investments | 21.58M | 21.84M | 11.00M | 8.49M | 7.08M |
| Total Debt | 0.00 | 23.00K | 44.00K | 68.00K | 0.00 |
| Total Liabilities | 7.67M | 13.28M | 9.93M | 5.62M | 2.81M |
| Stockholders Equity | 31.59M | 29.75M | 20.76M | 10.52M | 10.97M |
Cash Flow | |||||
| Free Cash Flow | 6.20M | 17.67M | 1.58M | 1.33M | -744.00K |
| Operating Cash Flow | 6.27M | 17.79M | 1.87M | 4.38M | 1.85M |
| Investing Cash Flow | -4.45M | -6.30M | -8.71M | -3.05M | -2.60M |
| Financing Cash Flow | -1.48M | 0.00 | 9.39M | 81.00K | 0.00 |
Kooth Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £59.67M | 21.02 | 8.84% | ― | -5.18% | -66.95% | |
61 Neutral | £18.07M | -4.21 | -15.57% | ― | 13.04% | 15.88% | |
53 Neutral | £208.30M | 48.37 | 2.09% | ― | 8.46% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | £516.14K | -0.03 | -56.95% | ― | ― | ― | |
46 Neutral | £17.00M | -8.22 | -58.72% | ― | -9.11% | 18.91% |
* Healthcare Sector Average
GB:KOO
Kooth
158.50
-31.00
-16.36%
GB:COG
Cambridge Cognition Holdings
31.50
-1.00
-3.08%
GB:IXI
IXICO plc
8.25
-1.50
-15.38%
GB:TRLS
Trellus Health PLC
0.12
-0.48
-80.00%
GB:OPT
Optima Health PLC
192.50
-0.51
-0.26%
Kooth Corporate Events
Business Operations and StrategyRegulatory Filings and Compliance
Kooth Updates Share Capital Following Treasury Transfer and Option Exercise
Neutral
Jun 26, 2026
Kooth plc has transferred 1,883 ordinary shares from its treasury to satisfy options exercised by a former employee under its Long Term Incentive Plan, slightly adjusting its capital structure. Following this transaction, the company’s issue...
Business Operations and StrategyShareholder Meetings
Kooth shareholders back growth strategy as all AGM resolutions pass
Positive
Jun 23, 2026
Kooth plc, a digital mental health specialist serving over 20 million users in the UK and US, leverages its Kooth, Qwell and Soluna platforms to provide accredited online therapeutic support, and is recognised as a leading provider for under-18s i...
Business Operations and StrategyExecutive/Board Changes
Kooth Adds US Behavioural Health Veteran James A. Polo to Board
Positive
May 19, 2026
Kooth Plc, a digital mental and behavioural health specialist, delivers online platforms such as Kooth, Qwell and Soluna to more than 20 million users across the UK and US, with a particular focus on youth and under-18s. The group combines self-he...
Business Operations and StrategyFinancial DisclosuresShareholder Meetings
Kooth publishes 2025 annual report and sets date for 2026 AGM
Positive
May 19, 2026
Kooth has published its 2025 annual report, which is now available on the company’s investor website, with physical copies to be sent to shareholders who have requested them. The company also confirmed that its 2026 annual general meeting wi...
Business Operations and StrategyProduct-Related Announcements
Kooth’s Soluna Platform Wins California Backing With Growing Impact on Youth Mental Health
Positive
Apr 20, 2026
Kooth has highlighted an independent impact report from California’s Department of Health Care Services confirming that its Soluna digital behavioural health platform is expanding its reach and delivering effective, safe and cost-efficient m...
Business Operations and StrategyFinancial Disclosures
Kooth Builds US Momentum With Soluna as 2025 Profits Beat Expectations
Positive
Apr 8, 2026
Kooth reported audited 2025 results that underscore a strategic pivot toward long-term, sustainable growth, led by the rapid embedding of its Soluna platform in California’s behavioural health system. By year-end, more than 144,000 young peo...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.